Treatment of depressive symptoms and attitudes towards treatment options in a representative German general population sample

International Journal of Psychiatry in Clinical Practice

Volumn 12, Issue 1, 2008, Pages 5-10

  Berner, Michael M ^a   Kriston, Levente ^a   Sitta, Petra ^a   Härter, Martin ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Depressive disorder; Health services research; Patient acceptance of health care; Phytotherapy; Therapeutics

Indexed keywords

ANTIDEPRESSANT AGENT; HYPERICUM PERFORATUM EXTRACT;

ADOLESCENT; ADULT; AGED; ARTICLE; DEPRESSION; DRUG SELF ADMINISTRATION; FEMALE; GERMANY; HUMAN; HYPERICUM PERFORATUM; MAJOR CLINICAL STUDY; MALE; PATIENT ATTITUDE; PATIENT COMPLIANCE; PHYTOTHERAPY; PRIORITY JOURNAL; PSYCHOTHERAPY; PUBLIC OPINION; SYMPTOMATOLOGY;

EID: 45849084952     PISSN: 13651501     EISSN: 14711788     Source Type: Journal    
DOI: 10.1080/13651500701330783     Document Type: Article

References (42)

1. Merry S, McDowell H, Hetrick S, Bir J, Muller N. Psychological and/or educational interventions for the prevention of depression in children and adolescents. Cochrane Database Syst Rev 2006;3.
2. Furukawa T, Streiner D, Young LY. V. Antidepressant and benzodiazepine for major depression. Cochrane Database Syst Rev 2006;3.
3. Williams JW Jr, Mulrow CD, Chiquette E, Noel PH, Aguilar C, Cornell J. A systematic review of newer pharmacotherapies for depression in adults: evidence report summary. Ann Intern Med 2000;132:743-56.
4. Ballenger JC, Davidson JR, Lecrubier Y, et al. Consensus statement on the primary care management of depression from the International Consensus Group on Depression and Anxiety. J Clin Psychiatry 1999;60:54-61.
5. Wittchen HU, Müller N, Schmidtkunz B, Winter S, Pfister H. [Manifestation, prevalence and management of depression. Results of the nationwide survey "Mental Disorders"]. [German]. Fortschr Med 2000;S1:4-9.
6. Wittchen HU, Winter S, Höfler M, et al. [Prevalence and recognition of depression in the general practice]. [German]. Fortschr Med 2000;S1:22-30.
7. Kessler RC, McGonagle KA, Zhao S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 1994;51:8-19.
8. Wittchen HU, Knauper B, Kessler RC. Lifetime risk of depression. Br J Psychiatry Suppl 1994;26:16-22.
9. Murray CJ, Lopez AD. The Global Burden of Disease: a Comprehensive Assessment of Mortality and Disability from Diseases, Injuries, and Risk Factors in 1990 and Projected to 2020. Geneva: World Health Organization; 1996.
10. Angermeyer MC, Dietrich S. Public beliefs about and attitudes towards people with mental illness: a review of population studies. Acta Psychiatr Scand 2006;113:163-79.
11. McKeon P, Gavigan P, Carrick S. Aware of depression ten years on: The irish perspective. Int J Methods Psychiatr Res 1996;6:S3-S8.
12. Peveler R, Kendrick T. Treatment delivery and guidelines in primary care. Br Med J 2001;57:193-206.
13. Kroll M, Dietrich S, Angermeyer MC. [The presentation of depression in German daily newspapers. A trend analysis]. [German]. Psychiatr Prax 2003;30:367-71.
14. Deutsche Gesellschaft für Psychiatrie PuND. [Practice Guidelines in Psychiatry and Psychotherapy: Treatment Guideline Affective Disorders]. [German]. Darmstadt: Steinkopff; 2000.
15. American Psychiatric Association (APA). Practice Guidelines for the Treatment of Major Depressive Disorders. Washington, DC: American Psychiatric Association; 2000.
16. Crismon ML, Trivedi M, Pigott TA, et al. V: The Texas Medication Algorithm Project: report of the Texas Consensus Conference Panel on medication treatment of major depressive disorder. J Clin Psychiatry 1999;60:142-56.
17. Depression Guideline Panel. Depression in primary care: Volume 1, Detection and diagnosis. Clinical practice guideline, Number 5. Rockville, MD: US Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research; 1993.
18. Katon W, Von Korff M, Lin E, et al. Collaborative management to achieve treatment guidelines. Impact on depression in primary care. J Am Med Assoc 1995;273:1026-31.
19. Paykel ES, Tylee A, Wright A, Priest RG, Rix S, Hart D. The defeat depression campaign: psychiatry in the public arena. Am J Psychiatry 1997;154:59-65.
20. Lin EH, Katon WJ, Simon GE, et al. Achieving guidelines for the treatment of depression in primary care: is physician education enough? Med Care 1997;35:831-42.
21. Schulberg HC, Katon WJ, Simon GE, Rush AJ. Best clinical practice: guidelines for managing major depression in primary medical care. J Clin Psychiatry 1999;60:19-26.
22. Finley PR, Rens HR, Pont JT, et al. V: Impact of a collaborative care model on depression in a primary care setting: A randomized, controlled trial. Pharmacotherapy 2003;23:1175-85.
23. Haerter M, Bermejo I, Niebling W, Schneider F, Berger M. [Networked care of depressive patients - development of a treatment corridor and implementation of evidence-based recommendations]. [German]. Z Allgemeinmed 2003;78:231-8.
24. Kendrick T. Why can't GPs follow guidelines on depression? Br Med J 2000;320:200-1.
25. Gilbody S, Whitty P, Grimshaw J, Thomas R. Educational and organizational interventions to improve the management of depression in primary care: a systematic review. J Am Med Assoc 2003;289:3145-51.
26. Oldehinkel AJ, Wittchen HU, Schuster P. Prevalence, 20-month incidence and outcome of unipolar depressive disorders in a community sample of adolescents. Psychol Med 1999;29:655-68.
27. Angermeyer MC, Matschinger M, Riedel-Heller SG. Whom to ask for help in case of a mental disorder? Preferences of the lay public. Soc Psychiatry Psychiatr Epidemiol 1999;34:202-10.
28. Priest RG, Vize C, Roberts A, Roberts M, Tylee A. Lay people's attitudes to treatment of depression: results of opinion poll for Defeat Depression Campaign just before its launch. Br Med J 1996;313:858-9.
29. Wernicke TF, Linden M. Clinical recognition and drug treatment of depression in cases found by standardized assessment. Pharmacopsychiatry 1994;27:54-7.
30. Hegerl U, Althaus D, Stefanek J. Public attitudes towards treatment of depression: effects of an information campaign. Pharmacopsychiatry 2003;36:288-91.
31. Degner D, Grohmann R, Kropp S, et al. Severe adverse drug reactions of antidepressants: results of the German multicenter drug surveillance program AMSP. Pharmacopsychiatry 2004;37(S1):S39-S45.
32. Donoghue JM, Tylee A. V: The treatment of depression: prescribing patterns of antidepressants in primary care in the UK. Br J Psychiatry 1996;168:164-8.
33. Angermeyer MC, Matschinger M. Lay beliefs about mental disorders: a comparison between the western and the eastern parts of Germany. Soc Psychiatry Psychiatr Epidemiol 1999;34:275-81.
34. Harrison P. Herbal medicine takes root in Germany. Can Med Assoc J 1998;158:637-9.
35. Katon W, Robinson P, VonKorff M, et al. A multifaced intervention to improve treatment of depression in primary care. Arch Gen Psychiatry 1996;53:924-32.
36. Kasper S. Hypericum perforatum - a review of clinical studies. Pharmacopsychiatry 2001;34(S1):S51-S55.
37. Linde K, Berner M, Egger M, Mulrow C. St John's wort for depression: meta-analysis of randomised controlled trials. Br J Psychiatry 2005;186:99-107.
38. Wurglics M, Schubert-Zsilavecz M. [Charge conformity and biopharmaceutic characterization. St. John's Wort extract preparations in comparison]. [German]. Pharm Unserer Zeit 2003;32:236-41.
39. Wurglics M, Westerhoff K, Kaunzinger A, et al. Comparison of German St. John's wort products according to hyperforin and total hypericin content. J Am Pharm Assoc (Washington) 2001;41:560-6.
40. Wurglics M, Westerhoff K, Kaunzinger A, Wilke A, Baumeister A, Dressman J, et al. Batch-to-batch reproducibility of St. John's wort preparations. Pharmacopsychiatry 2001;34(S1):S152-S156.
41. Walsh BT, Seidman SN, Sysko R, Gould M. Placebo response in studies of major depression: variable, substantial, and growing. J Am Med Assoc 2002;287:1840-7.
42. Scogin FR, Hanson A, Welsh D. Self-administered treatment in stepped-care models of depression treatment. J Clin Psychol 2003;59:341-9.